Medeloop, a Menlo Park, CA-based medical research platform, raised $15.5M in Series A funding.
The round was led by Inovia Capital with participation from Icon Ventures, General Catalyst and Maven Ventures, as well as new investors including Healthier Capital, Up2 Opportunity Fund, and CFO Advisors.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Rene Caissie, Medeloop is a provider of an AI-driven medical research platform that automates the entire research cycle, from grant discovery to data analysis, by transforming medical data into a graph database for deep insights and fast results.
The comprehensive suite includes a grant platform for identifying and applying for funding, a dual-component studies platform featuring a mobile app for participants and a web app for researchers, a no-code analytics platform for rapid data analysis, and a manuscript publication platform. These tools are integrated, designed to allow researchers to efficiently manage every aspect of a study from inception to publication.
Medeloop partners with healthcare institutions worldwide.
